MSCI - Mergers and acquisitions

MSCI Inc. (NYSE:MSCI) is enhancing its global physical climate risk capabilities with the acquisition of First Street, a leading provider of physics-based climate risk data and analytics for every property in the world. Investors, financial institutions and companies are demanding physical climate risk insights embedded directly into investment and risk workflows to inform critical financial decision making, as climate-related physical risks accelerate globally. First Street’s own research shows that companies have become more than 6.5 times as likely to issue profit warnings following extreme weather events in the past two decades.i The integration of First Street’s data and tools into

NEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (NASDAQ:RPRX) today announced a collaboration with MSCI Inc. (NYSE:MSCI), a leading provider of critical decision support tools and services for the global investment community, to expand MSCI's thematic index suite with the launch of new indexes that aim to capture long-term, cutting edge themes that will disrupt the life sciences, biotechnology and pharmaceutical industry groups. Royalty Pharma will provide expertise on various medical conditions, clinical trials, transformative therapies, and technologies that may lead to breakthrough medical treatments that will assist MSCI to design a classification framework and index m